Michael Thase

Michael E. Thase is Professor of Psychiatry in the Department of Psychiatry of the Perelman School of Medicine of the University of Pennsylvania and the Corporal Michael J Crescenz Veterans Affairs Medical Center. A 1979 graduate of The Ohio State University College Medicine, Professor Thase completed internship, residency, chief residency, and post-doctoral training in clinical research at the University of Pittsburgh Medical Center (UPMC), where he rose to the rank of Professor of Psychiatry and was Chief of the Division of Academic Adult Psychiatry before he moved to Philadelphia in 2007. A renowned teacher, mentor, administrator, researcher, and clinician. Dr. Thase is a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of the American College of Neuropsychopharmacology and, a member of the American College of Psychiatrists. In 2019, he was elected to the membership of Penn Medicine’s Academy of Master Clinicians, an honor bestowed to only 2% of the medical faculty. He is a Past President of the American Society of Clinical Psychopharmacology. Professor Thase is a Founding Fellow of the Academy of Cognitive Therapy, and a member of advisory boards for the Anxiety and Depressive Disorders Association, the National Network of Depression Centers, the Depression and Bipolar Support Alliance and the American Foundation for Suicide Prevention. A highly cited psychiatrist, his 1300+ publications include numerous citation classics. His research has been continuously funded by federal agencies for the past 40 years and focuses on novel therapies for difficult to treat depression and CBT.

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Michael E. Thase is Professor of Psychiatry in the Department of Psychiatry of the Perelman School of Medicine of the University of Pennsylvania and the Corporal Michael J Crescenz Veterans Affairs Medical Center. A 1979 graduate of The Ohio State University College Medicine, Professor Thase completed internship, residency, chief residency, and post-doctoral training in clinical research at the University of Pittsburgh Medical Center (UPMC), where he rose to the rank of Professor of Psychiatry and was Chief of the Division of Academic Adult Psychiatry before he moved to Philadelphia in 2007. A renowned teacher, mentor, administrator, researcher, and clinician. Dr. Thase is a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of the American College of Neuropsychopharmacology and, a member of the American College of Psychiatrists. In 2019, he was elected to the membership of Penn Medicine’s Academy of Master Clinicians, an honor bestowed to only 2% of the medical faculty. He is a Past President of the American Society of Clinical Psychopharmacology. Professor Thase is a Founding Fellow of the Academy of Cognitive Therapy, and a member of advisory boards for the Anxiety and Depressive Disorders Association, the National Network of Depression Centers, the Depression and Bipolar Support Alliance and the American Foundation for Suicide Prevention. A highly cited psychiatrist, his 1300+ publications include numerous citation classics. His research has been continuously funded by federal agencies for the past 40 years and focuses on novel therapies for difficult to treat depression and CBT.